A Belfast man with limited vision has told of how he hopes to help “advance eye health, raise awareness and transform lives” ...

GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

From redness to gradual loss of vision to constant irritation, here are the early warning signs of eye diseases that should ...

For the second year in a row, Bausch + Lomb has joined with the Glaucoma Research Foundation to launch the “Faces of Glaucoma ...

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients ...

More than 4.2 million Americans live with glaucoma, a leading cause of vision loss in the nation. Although there is no cure for glaucoma, early detection and treatment can stop this condition in its ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Some people have labeled glaucoma as the quiet disease, until it steals your vision, and then there are symptoms. In this ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit ...